Global OTC Digestives and Intestinal Remedies 麻豆原创 Research Report 2024

Publication ID:

PB502250718

Publication Date:

February 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

OTC Digestives and Intestinal Remedies are used for the treatment of gastrointestinal (GI) disorders. The most common digestive disorders are indigestion, heartburn, diarrhea, irritable bowel syndrome (IBS), motion sickness, pediatric digestive disorders, and constipation.
The global OTC Digestives and Intestinal Remedies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for OTC Digestives and Intestinal Remedies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Digestives and Intestinal Remedies.
Report Scope
The OTC Digestives and Intestinal Remedies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Digestives and Intestinal Remedies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Digestives and Intestinal Remedies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Johnson and Johnson
Novartis AG
Bayer AG
Sanofi
Pfizer
GlaxoSmithKline PLC
Perrigo Company PLC
Reckitt Benckiser Group PLC
Takeda Pharmaceutical Company Ltd
Cipla
Procter & Gamble Company
Segment by Type
Pills
Powder
Capsules
Liquids
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Digestives and Intestinal Remedies companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global OTC Digestives and Intestinal Remedies 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pills
1.2.3 Powder
1.2.4 Capsules
1.2.5 Liquids
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global OTC Digestives and Intestinal Remedies 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Digestives and Intestinal Remedies 麻豆原创 Perspective (2019-2030)
2.2 OTC Digestives and Intestinal Remedies Growth Trends by Region
2.2.1 Global OTC Digestives and Intestinal Remedies 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 OTC Digestives and Intestinal Remedies Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 OTC Digestives and Intestinal Remedies Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 OTC Digestives and Intestinal Remedies 麻豆原创 Dynamics
2.3.1 OTC Digestives and Intestinal Remedies Industry Trends
2.3.2 OTC Digestives and Intestinal Remedies 麻豆原创 Drivers
2.3.3 OTC Digestives and Intestinal Remedies 麻豆原创 Challenges
2.3.4 OTC Digestives and Intestinal Remedies 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Digestives and Intestinal Remedies Players by Revenue
3.1.1 Global Top OTC Digestives and Intestinal Remedies Players by Revenue (2019-2024)
3.1.2 Global OTC Digestives and Intestinal Remedies Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global OTC Digestives and Intestinal Remedies 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Digestives and Intestinal Remedies Revenue
3.4 Global OTC Digestives and Intestinal Remedies 麻豆原创 Concentration Ratio
3.4.1 Global OTC Digestives and Intestinal Remedies 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Digestives and Intestinal Remedies Revenue in 2023
3.5 OTC Digestives and Intestinal Remedies Key Players Head office and Area Served
3.6 Key Players OTC Digestives and Intestinal Remedies Product Solution and Service
3.7 Date of Enter into OTC Digestives and Intestinal Remedies 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Digestives and Intestinal Remedies Breakdown Data by Type
4.1 Global OTC Digestives and Intestinal Remedies Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global OTC Digestives and Intestinal Remedies Forecasted 麻豆原创 Size by Type (2025-2030)
5 OTC Digestives and Intestinal Remedies Breakdown Data by Application
5.1 Global OTC Digestives and Intestinal Remedies Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global OTC Digestives and Intestinal Remedies Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America OTC Digestives and Intestinal Remedies 麻豆原创 Size (2019-2030)
6.2 North America OTC Digestives and Intestinal Remedies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2019-2024)
6.4 North America OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Digestives and Intestinal Remedies 麻豆原创 Size (2019-2030)
7.2 Europe OTC Digestives and Intestinal Remedies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2019-2024)
7.4 Europe OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Digestives and Intestinal Remedies 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific OTC Digestives and Intestinal Remedies 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific OTC Digestives and Intestinal Remedies 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific OTC Digestives and Intestinal Remedies 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Digestives and Intestinal Remedies 麻豆原创 Size (2019-2030)
9.2 Latin America OTC Digestives and Intestinal Remedies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2019-2024)
9.4 Latin America OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Digestives and Intestinal Remedies 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa OTC Digestives and Intestinal Remedies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa OTC Digestives and Intestinal Remedies 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson OTC Digestives and Intestinal Remedies Introduction
11.1.4 Johnson and Johnson Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.1.5 Johnson and Johnson Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG OTC Digestives and Intestinal Remedies Introduction
11.2.4 Novartis AG Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.2.5 Novartis AG Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Detail
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG OTC Digestives and Intestinal Remedies Introduction
11.3.4 Bayer AG Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.3.5 Bayer AG Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi OTC Digestives and Intestinal Remedies Introduction
11.4.4 Sanofi Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer OTC Digestives and Intestinal Remedies Introduction
11.5.4 Pfizer Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 GlaxoSmithKline PLC
11.6.1 GlaxoSmithKline PLC Company Detail
11.6.2 GlaxoSmithKline PLC Business Overview
11.6.3 GlaxoSmithKline PLC OTC Digestives and Intestinal Remedies Introduction
11.6.4 GlaxoSmithKline PLC Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.6.5 GlaxoSmithKline PLC Recent Development
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Detail
11.7.2 Perrigo Company PLC Business Overview
11.7.3 Perrigo Company PLC OTC Digestives and Intestinal Remedies Introduction
11.7.4 Perrigo Company PLC Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.7.5 Perrigo Company PLC Recent Development
11.8 Reckitt Benckiser Group PLC
11.8.1 Reckitt Benckiser Group PLC Company Detail
11.8.2 Reckitt Benckiser Group PLC Business Overview
11.8.3 Reckitt Benckiser Group PLC OTC Digestives and Intestinal Remedies Introduction
11.8.4 Reckitt Benckiser Group PLC Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.8.5 Reckitt Benckiser Group PLC Recent Development
11.9 Takeda Pharmaceutical Company Ltd
11.9.1 Takeda Pharmaceutical Company Ltd Company Detail
11.9.2 Takeda Pharmaceutical Company Ltd Business Overview
11.9.3 Takeda Pharmaceutical Company Ltd OTC Digestives and Intestinal Remedies Introduction
11.9.4 Takeda Pharmaceutical Company Ltd Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.9.5 Takeda Pharmaceutical Company Ltd Recent Development
11.10 Cipla
11.10.1 Cipla Company Detail
11.10.2 Cipla Business Overview
11.10.3 Cipla OTC Digestives and Intestinal Remedies Introduction
11.10.4 Cipla Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.10.5 Cipla Recent Development
11.11 Procter & Gamble Company
11.11.1 Procter & Gamble Company Company Detail
11.11.2 Procter & Gamble Company Business Overview
11.11.3 Procter & Gamble Company OTC Digestives and Intestinal Remedies Introduction
11.11.4 Procter & Gamble Company Revenue in OTC Digestives and Intestinal Remedies Business (2019-2024)
11.11.5 Procter & Gamble Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Johnson and Johnson
Novartis AG
Bayer AG
Sanofi
Pfizer
GlaxoSmithKline PLC
Perrigo Company PLC
Reckitt Benckiser Group PLC
Takeda Pharmaceutical Company Ltd
Cipla
Procter & Gamble Company

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.